These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38992193)

  • 1. Effectiveness of platelet-rich plasma in long-lasting post-viral olfactory dysfunction: a case-series.
    Lechien JR; Saussez S
    Eur Arch Otorhinolaryngol; 2024 Nov; 281(11):5841-5846. PubMed ID: 38992193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study.
    Lechien JR; Saussez S; Vaira LA; De Riu G; Boscolo-Rizzo P; Tirelli G; Michel J; Radulesco T
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):84-91. PubMed ID: 37522295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
    Lechien JR; Le Bon SD; Saussez S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients With Persistent Olfactory Dysfunction: Description of the Technique.
    Lechien JR; Saussez S
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):115S-119S. PubMed ID: 36219733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
    Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
    Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19.
    Steffens Y; Le Bon SD; Lechien J; Prunier L; Rodriguez A; Saussez S; Horoi M
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5951-5953. PubMed ID: 35904632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical platelet-rich plasma as a possible treatment for olfactory dysfunction-A randomized controlled trial.
    Duffy A; Naimi B; Garvey E; Hunter S; Kumar A; Kahn C; Farquhar D; D'Souza G; Rawson N; Dalton P; Toskala E; Rabinowitz M; Rosen M; Nyquist G; Rosen D
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1455-1464. PubMed ID: 38722276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-rich plasma for the treatment of COVID-19 related olfactory dysfunction: a systematic review.
    AlRajhi B; Alrodiman OA; Alhuzali AF; Alrashed H; Alrodiman YA; Alim B
    Rhinology; 2023 Dec; 61(6):498-507. PubMed ID: 37772881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of platelet-rich plasma on post-COVID chronic olfactory dysfunction.
    Evman MD; Cetin ZE
    Rev Assoc Med Bras (1992); 2023; 69(11):e20230666. PubMed ID: 37909619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of platelet-rich plasma in treatment of olfactory dysfunction: A pilot study.
    Yan CH; Mundy DC; Patel ZM
    Laryngoscope Investig Otolaryngol; 2020 Apr; 5(2):187-193. PubMed ID: 32337347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.
    Lechien JR; Wajsblat S; Horoi M; Boscolo-Rizzo P; Le Bon SD; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3461-3467. PubMed ID: 36943439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis.
    Kattar N; Do TM; Unis GD; Migneron MR; Thomas AJ; McCoul ED
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):244-254. PubMed ID: 32660334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of a french version of the olfactory disorders questionnaire.
    Lechien JR; Vaira LA; Le Bon SD; Geerts R; Boscolo-Rizzo P; Saussez S
    J Otolaryngol Head Neck Surg; 2022 Oct; 51(1):36. PubMed ID: 36182947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analyses of post-infectious olfactory dysfunction between COVID-19 and non-COVID-19 cases.
    Eo TS; Jeong Y; Cho HJ; Rha MS; Kim CH
    Sci Rep; 2024 Oct; 14(1):23511. PubMed ID: 39379543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training.
    Chan KH; Thomas BJ; Gilbert DD; Tong S; Teynor NJ; Friedman NR; Herrmann BW; Gitomer SA
    Int J Pediatr Otorhinolaryngol; 2024 Jan; 176():111799. PubMed ID: 38081110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaining Back What Is Lost: Recovering the Sense of Smell in Mild to Moderate Patients After COVID-19.
    Iannuzzi L; Salzo AE; Angarano G; Palmieri VO; Portincasa P; Saracino A; Gelardi M; Dibattista M; Quaranta N
    Chem Senses; 2020 Dec; 45(9):875-881. PubMed ID: 33033827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.
    Schmidt F; Azar C; Goektas O
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):48S-53S. PubMed ID: 36976171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Community-Based Study on the Prevalence of Olfactory Dysfunction.
    Schlosser RJ; Desiato VM; Storck KA; Nguyen SA; Hill JB; Washington BJ; Noonan TE; Lamira J; Mulligan JK; Rowan NR; Yoo F; Matthews LJ; Dubno JR; Soler ZM
    Am J Rhinol Allergy; 2020 Sep; 34(5):661-670. PubMed ID: 32345032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of postviral olfactory loss: follow-up study for longer than one year.
    Lee DY; Lee WH; Wee JH; Kim JW
    Am J Rhinol Allergy; 2014; 28(5):419-22. PubMed ID: 25198029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.